These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36535007)

  • 1. The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy.
    Karimi-Shahri M; Alalikhan A; Hashemian P; Hashemzadeh A; Javid H
    Nanotechnology; 2023 Mar; 34(21):. PubMed ID: 36535007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.
    Aggarwal V; Tuli HS; Tania M; Srivastava S; Ritzer EE; Pandey A; Aggarwal D; Barwal TS; Jain A; Kaur G; Sak K; Varol M; Bishayee A
    Semin Cancer Biol; 2022 May; 80():256-275. PubMed ID: 32461153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
    Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
    Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
    Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review.
    Ferrari E; Bettuzzi S; Naponelli V
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.
    Talib WH; Awajan D; Alqudah A; Alsawwaf R; Althunibat R; Abu AlRoos M; Al Safadi A; Abu Asab S; Hadi RW; Al Kury LT
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer.
    Bimonte S; Cascella M; Leongito M; Palaia R; Caliendo D; Izzo F; Cuomo A
    Recenti Prog Med; 2017 Jun; 108(6):282-287. PubMed ID: 28631776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of EGCG: a patent review.
    Chakrawarti L; Agrawal R; Dang S; Gupta S; Gabrani R
    Expert Opin Ther Pat; 2016 Aug; 26(8):907-16. PubMed ID: 27338088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment.
    Marín V; Burgos V; Pérez R; Maria DA; Pardi P; Paz C
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies.
    Mehmood S; Maqsood M; Mahtab N; Khan MI; Sahar A; Zaib S; Gul S
    J Food Biochem; 2022 Aug; 46(8):e14189. PubMed ID: 35474461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemico-biological aspects of
    Sahadevan R; Singh S; Binoy A; Sadhukhan S
    Crit Rev Food Sci Nutr; 2023; 63(30):10382-10411. PubMed ID: 35491671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
    James KD; Forester SC; Lambert JD
    Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
    Granja A; Pinheiro M; Reis S
    Nutrients; 2016 May; 8(5):. PubMed ID: 27213442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin 3-gallate: From green tea to cancer therapeutics.
    Alam M; Ali S; Ashraf GM; Bilgrami AL; Yadav DK; Hassan MI
    Food Chem; 2022 Jun; 379():132135. PubMed ID: 35063850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy.
    Li K; Teng C; Min Q
    Front Chem; 2020; 8():573297. PubMed ID: 33195062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanisms of anticancer activities of green tea component epigallocatechin- 3-gallate.
    Zhang L; Wei Y; Zhang J
    Anticancer Agents Med Chem; 2014; 14(6):779-86. PubMed ID: 24851882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.